Company Completely Halts Generic Lipitor Production After Recall
Indian generic drugmaker Ranbaxy Laboratories will stop manufacturing its version of Pfizer Inc's cholesterol fighter, Lipitor, while it gets to the bottom of the cause of a recent recall, the U.S. Food and Drug Administration said on its website.
Join the discussion below, or Read more at The Huffington Post.
#1 Dec 6, 2012
No matter what the result of Ranbaxy's invesigation,it will lose 90% of its generic atorvastating business in the US. market which would have been $ 150 mm +in 2013.
Add your comments below
|Pfizer, Allergan in deal talks to create drug g... (Oct '15)||Nov '16||Fubar||5|
|RPT-Trump presidency could prove a salve for ph...||Nov '16||tomin cali||1|
|3 tax loopholes Hillary Clinton wants to close (Oct '16)||Oct '16||Captain Yesterday||24|
|NantWorks deal looks dead (Sep '16)||Sep '16||Duke defender||1|
|Lawsuits filed over Lipitor side effects (Jun '06)||Sep '16||Kathy||848|
|Pfizer agrees to note addiction risks in opioid... (Jul '16)||Jul '16||BHM5267||2|
|Study: No suicide risk for anti-smoking pills (Apr '16)||Apr '16||SUS||2|
Find what you want!
Search Pfizer Forum Now
Copyright © 2017 Topix LLC